Graft-versus-myeloma effect [25]

Lancet

Volumn 348, Issue 9023, 1996, Pages 346-

  Aschan, J ^a   Lonnqvist, B ^a   Ringden, O ^a   Kumlien, G ^a   Gahrton, G ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; INTERLEUKIN 2; M PROTEIN; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTINEOPLASTIC ACTIVITY; CASE REPORT; CLINICAL FEATURE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; LEUKOCYTE; MALE; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL; REMISSION;

EID: 0030016598     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64525-4     Document Type: Letter

References (3)

1. L Verdonck H Lokhorst A Dekker K Nieuwenhuis E Petersen Graft-versus-myeloma effect in two cases Lancet 347 1996 800 801
2. G Tricot D Vesole S Jagannath J Hilton N Munshi B Barlogie Graft-versus-myeloma effect: proof of principle Blood 87 1996 1196 1198
3. HJ Kolb A Schattenberg JM Goldman Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 86 1995 2041 2050